Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Sumida Y, Yoneda M, Seko Y, Ishiba H, Hara T, Toyoda H, Yasuda S, Kumada T, Hayashi H, Kobayashi T, Imajo K, Yoneda M, Tada T, Kawaguchi T, Eguchi Y, Oeda S, Takahashi H, Tomita E, Okanoue T, Nakajima A, Japan Study Group Of Nafld Jsg-Nafld. Sumida Y, et al. Among authors: tomita e. Diagnostics (Basel). 2020 Aug 10;10(8):579. doi: 10.3390/diagnostics10080579. Diagnostics (Basel). 2020. PMID: 32785100 Free PMC article. Review.
Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study.
Imai K, Takai K, Nishigaki Y, Shimizu S, Naiki T, Hayashi H, Uematsu T, Sugihara J, Tomita E, Shimizu M, Nagaki M, Moriwaki H. Imai K, et al. Among authors: tomita e. Hepatol Res. 2010 Apr;40(4):376-82. doi: 10.1111/j.1872-034X.2009.00616.x. Epub 2010 Mar 4. Hepatol Res. 2010. PMID: 20236359
Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test.
Suzuki Y, Imai K, Takai K, Hanai T, Hayashi H, Naiki T, Nishigaki Y, Tomita E, Shimizu M, Moriwaki H. Suzuki Y, et al. Among authors: tomita e. J Cancer Res Clin Oncol. 2013 May;139(5):845-52. doi: 10.1007/s00432-013-1389-1. Epub 2013 Feb 15. J Cancer Res Clin Oncol. 2013. PMID: 23411687 Free article.
Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial.
Otsuji K, Takai K, Nishigaki Y, Shimizu S, Hayashi H, Imai K, Suzuki Y, Hanai T, Ideta T, Miyazaki T, Tomita E, Shimizu M, Moriwaki H. Otsuji K, et al. Among authors: tomita e. Hepatol Res. 2015 May;45(5):514-22. doi: 10.1111/hepr.12376. Epub 2014 Jul 24. Hepatol Res. 2015. PMID: 24961745
198 results